Investor
Forefront Analytics, LLC
CIK 0001696802 · filed 2026-05-13 · SEC filing
13F book
$110M
Positions
39
4 new · 8 sold
Largest name
22.1%
Ishares Tr
Est. mark
$1.03M
Price effect on 35 names still held. Flow −$4.34M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Ishares Tr | — | 254.4K | $24.3M | 22.1% | $111.9K | Added$4.25M |
| Ishares Inc | — | 369.5K | $16.8M | 15.3% | $472.8K | Added$733.2K |
| Vanguard Intl Equity Index F | — | 180.2K | $9.74M | 8.9% | $52.5K | Cut$1.81K |
| Ishares Tr | — | 68.1K | $9.24M | 8.4% | $960.3K | Cut$811.8K |
| Nushares Etf Tr | — | 195.7K | $8.9M | 8.1% | $63.6K | Added$2.53M |
| Flexshares Tr | — | 44.2K | $8.84M | 8.0% | −$123.7K | Added$4.12M |
| Dbx Etf Tr | — | 126.9K | $6.27M | 5.7% | $163.3K | Cut$117.1K |
| Ishares Tr | — | 24.2K | $5.82M | 5.3% | −$250.1K | Cut−$6.86M |
| Vanguard Tax-Managed Fds | — | 47.3K | $3.03M | 2.8% | $76.1K | Cut−$4.67M |
| Ishares Tr | — | 4.47K | $2.92M | 2.7% | −$141.9K | Cut−$301.4K |
| Nvidia Corp | NVDA | 14.2K | $2.48M | 2.3% | −$169.6K | Added−$123.4K |
| Ishares Inc | — | 58.5K | $2.16M | 2.0% | $126.4K | Cut$69.8K |
| Jpmorgan Chase & Co. | — | 4.98K | $1.47M | 1.3% | −$93.7K | Added$386K |
| Deere & Co | DE | 1.14K | $640.2K | 0.6% | $110.5K | Added$112.2K |
| Unitedhealth Group Inc | UNH | 1.98K | $536.6K | 0.5% | −$86.3K | Added$57.3K |
| Edwards Lifesciences Corp | EW | 6.57K | $526.4K | 0.5% | −$31.6K | Added$5.31K |
| Abbott Labs | ABT | 5.04K | $517.7K | 0.5% | −$85K | Added$47.2K |
| Wisdomtree Tr | — | 8.23K | $477.9K | 0.4% | $9.24K | Cut−$533.2K |
| Schwab Strategic Tr | — | 15.1K | $463.9K | 0.4% | — | New |
| Medtronic Plc | MDT | 5.32K | $460.9K | 0.4% | −$40.2K | Added$49.8K |
| Proshares Tr | — | 8.16K | $423.6K | 0.4% | −$49.2K | Added−$48.3K |
| Incyte Corp | INCY | 4.23K | $398.4K | 0.4% | −$19.7K | Cut−$115K |
| Proshares Tr | — | 7.99K | $372.9K | 0.3% | −$2.81K | Added−$2.2K |
| Pfizer Inc | PFE | 13.1K | $367.6K | 0.3% | $41.6K | Cut−$108.1K |
| Blue Owl Technology Fin Corp | — | 29.7K | $367.4K | 0.3% | — | New |
| Regeneron Pharmaceuticals, Inc. | REGN | 460 | $355K | 0.3% | $117 | Added$25.6K |
| Thermo Fisher Scientific Inc. | TMO | 579 | $284.6K | 0.3% | −$50.8K | Cut−$54.9K |
| Legend Biotech Corp | LEGN | 15.7K | $283.3K | 0.3% | — | New |
| Vanguard Index Fds | — | 1.32K | $258.5K | 0.2% | $6.93K | Cut−$403.3K |
| Danaher Corporation | — | 1.29K | $244.2K | 0.2% | −$36K | Added$34.7K |
| Philip Morris Intl Inc | — | 1.45K | $239.7K | 0.2% | $7.52K | Added$9.66K |
| Dimensional Etf Trust | — | 6.34K | $222.2K | 0.2% | — | New |
| Nkarta, Inc. | NKTX | 43.8K | $92.5K | 0.1% | $10.6K | Added$17.2K |
| Zura Bio Ltd | ZURA | 14.9K | $88.7K | 0.1% | $10.6K | Cut−$13.9K |
| Geron Corp | GERN | 55.1K | $82.1K | 0.1% | $8.72K | Added$14.4K |
| Annexon, Inc. | ANNX | 14.2K | $78.9K | 0.1% | $6.88K | Added$12.5K |
| Bicycle Therapeutics Plc | BCYC | 14.4K | $66.8K | 0.1% | −$32.6K | Added−$27.9K |
| CytomX Therapeutics, Inc. | CTMX | 12.5K | $58.6K | 0.1% | $5.49K | Cut−$21K |
| Mereo Biopharma Group Plc | MREO | 127.8K | $42.2K | 0.0% | −$2.75K | Added$28.9K |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.